Lymphangiogenesis and cancer metastasis

被引:29
作者
Al-Rawi, Mahir A. A. [1 ]
Jiang, Wen G. [2 ]
机构
[1] Betsi Cadwaladr Univ, Hlth Board, Glan Clwyd Hosp, Dept Surg, Rhyl LL18 5UJ, Denbigh, Wales
[2] Cardiff Univ, Dept Surg, Sch Med, Cardiff CF14 4XN, S Glam, Wales
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2011年 / 16卷
关键词
Lymphangiogenesis; cancer; lymphatic; metastasis; Review; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; FACTOR-C EXPRESSION; SQUAMOUS-CELL CARCINOMAS; HUMAN COLORECTAL-CANCER; FACTOR-RELATED PROTEIN; WEIBEL-PALADE BODIES; ANGIOGENESIS IN-VIVO; D VEGF-D; FACTOR RECEPTOR-3;
D O I
10.2741/3715
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lymphangiogenesis remains a fascinating biological process that plays a crucial role in both normal tissue development and several lymphatic diseases. The last few years have witnessed a rapid progression in understanding the development and regulation of the lymphatic system which provided insight on several pathological processes including cancer lymphatic metastasis. Lymphatic vasculature serves as a major route for tumour metastasis. The dissemination of malignant cells to the regional lymph nodes is an early step in the progression of many solid tumours and is an important determinant of staging and prognosis. Lymphangiogenesis is thought to play a pivotal role for cancer cells to metastasise to the regional lymph nodes. Several human solid tumours are now considered to be lymphangiogenic i.e. they have the ability to induce their own lymphatic vessels to establish metastasis. Hence, targeting lymphangiogenesis by developing anti-lymphangiogenic agents might constitute a novel way to prevent lymphatic progression in some tumours. Here, we have reviewed the development of the lymphatic system, the regulation of lymphangiogenesis and explored its relation to several human cancers.
引用
收藏
页码:723 / 739
页数:17
相关论文
共 176 条
[1]  
Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO
[2]  
2-G
[3]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[4]   Focus on lymphangiogenesis in tumor metastasis [J].
Achen, MG ;
McColl, BK ;
Stacker, SA .
CANCER CELL, 2005, 7 (02) :121-127
[5]   Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues [J].
Akagi, K ;
Ikeda, Y ;
Miyazaki, M ;
Abe, T ;
Kinoshita, J ;
Maehara, Y ;
Sugimachi, K .
BRITISH JOURNAL OF CANCER, 2000, 83 (07) :887-891
[6]   Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β [J].
Akagi, Y ;
Liu, W ;
Xie, K ;
Zebrowski, B ;
Shaheen, RM ;
Ellis, LM .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1506-1511
[7]  
Al-Rawi MAA, 2003, BREAST CANCER RES TR, V82, pS134
[8]  
Alitalo K, 1997, EUR J CANCER, V33, P1017
[9]   Molecular mechanisms of lymphangiogenesis in health and disease [J].
Alitalo, K ;
Carmeliet, P .
CANCER CELL, 2002, 1 (03) :219-227
[10]   Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa [J].
Amioka, T ;
Kitadai, Y ;
Tanaka, S ;
Haruma, K ;
Yoshihara, M ;
Yasui, W ;
Chayama, K .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (10) :1413-1419